Laserfiche WebLink
Table 6. (continued) <br />Organism and arsenical <br />Effect <br />Referencea <br />Arsenic trioxide Air c2ncentrations of 28.5 <br /> mg/m for 4 hours daily on <br /> days 9 to 12 of gestation <br /> caused fetotoxic effects <br /> and chromosomal damage to <br /> liver cells by day 18; effects <br /> included reduced survival, <br /> impaired growth, retarded <br /> limb ossification, and bone3 <br /> abnormalities. At 2.9 mg/m , <br /> a 9.9% decrease in fetal weight <br /> was recorded; at 0.26 mg/m , a <br /> 3.1% decrease was measured. <br />Cacodylic acid Oral dosages of 400 to 600 <br /> mg/kg BW on days 7 to 16 of <br /> gestation produces fetal mal- <br /> formations (cleft palate), de- <br /> layed skeletal ossification, <br /> and fetal weight reduction. <br />Sodium arsenate Maximum tolerated doses in terms <br /> of abortion or maternal death <br /> over 24 hours in 18-day+9reg- <br /> nant mice were 20 mg As /kg <br /> BW, intraperitoneal route, and <br /> 50 mg/kg BW when administered <br /> orally. Residue half-life was <br /> about 10 hours regardless of route <br /> of administration. <br />Sodium arsenite Fed 5 mg/kg diet for three genera- <br /> tions: reduced litter size, but <br /> outwardly normal. <br />Sodium arsenite LD-50 of 9.6 mg/kg BW, subcuta- <br /> neous route; LD-90 (7 days post- <br /> administration) of 11.3 mg/kg BW, <br /> subcutaneous route. <br />Sodium arsenite LD-50 of 12 mg/kg BW intraperi- <br /> toneal route. At 10 mg/kg BW, <br /> damage to bone marrow and sperm. <br />Sodium cacodylate Single intraperitoneal injection <br /> of 1,200 mg/kg BW during mid- <br />13 <br />5 <br />14 <br />6 <br />15 <br />16 <br />gestation results in increased rates <br />of fetal skeletal malformations. 5 <br />67